Steven Schellings

Steven Schellings has over 15 years of experience in the pharmaceutical industry. Steven most recently served as an Associate Director, Strategic Accounts at ImmunoGen, Inc. Their previous positions include roles at MorphoSys, Novartis, Merck, ARIAD Pharmaceuticals, Bristol-Myers Squibb Oncology, and Eisai, Inc. Throughout their career, Steven has demonstrated expertise in account management, government programs, and strategic planning. Steven has successfully launched cancer therapies, collaborated with key opinion leaders, managed industry partnerships, and built strong professional relationships. Their experience spans a range of therapeutic areas, including oncology, hematology, and critical care.

Steven Schellings has a Master of Public Administration (MPA) degree in Public Administration and Policy from the Evans School of Public Policy & Governance, University of Washington. Steven also holds a Bachelor of Science (BS) degree in Communications from California Polytechnic State University-San Luis Obispo.